About Alnylam Pharma (ALNY)
Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The Company is focused on the use of its N-acetylgala... Read more
- USD154.41
- USD155.41
- USD152.09
- USD218.88
- -0.50%
- 1.8B
- 51.47k
- 525.38k
- 18.0B
- 141.98
- -24.50%
Stock News
1 hour ago
Dow Jones Futures Rally 500 Points On Weak Jobs Report; Apple Surges On Buyback News
Yahoo
1 hour ago
Shenandoah Telecommunications Reports Mixed Q1 2024 Results Amidst Major Transactions
Yahoo
1 hour ago
Trimble Inc (TRMB) Q1 2024 Earnings: Surpasses Revenue Forecasts with Strategic Growth Initiatives
Yahoo
1 hour ago
April NZ new vehicle sales slow with start of financial year
Yahoo
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
